A carregar...
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
Fingolimod is a selective immunosuppressive agent approved worldwide for the treatment of relapsing-remitting multiple sclerosis (MS), a chronic and potentially disabling neurological condition. Randomized double-blind clinical trials have shown that fingolimod significantly reduces relapse rate and...
Na minha lista:
| Publicado no: | Drug Healthc Patient Saf |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4686225/ https://ncbi.nlm.nih.gov/pubmed/26715860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S69640 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|